Literature DB >> 30824578

Rapid onset and progression of myelopathy following an STI: a case for screening?

Rachel J Caswell1, Peter Nall2, Meg Boothby3, Graham P Taylor2.   

Abstract

Human T lymphotropic virus type 1 (HTLV-1) is recognised as an STI with serious manifestations of the disease in approximately 10% of those infected. This case report is the first to describe the short interval from sexual acquisition of HTLV-1 to the onset of HTLV-1-associated myelopathy and rapid progression to spastic paraparesis. The number of adult infections in the UK per annum is unknown, but surveillance data indicate that around 30% of newly diagnosed infections are occurring in persons born in the UK, rather than in migrants from HTLV-1-endemic regions. Despite this, and despite the risk of chronic debilitating disease, HTLV-1 infection is not part of sexual health screening in the UK, with the consequence that patients requesting sexual health screens are not informed of their carrier status and transmission from asymptomatic carriers to the partners will continue. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  HTLV-1; genitourinary medicine; sexual health

Mesh:

Year:  2019        PMID: 30824578     DOI: 10.1136/sextrans-2019-053978

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  7 in total

Review 1.  Pre-Exposure Prophylaxis for viral infections other than HIV.

Authors:  Vicente Soriano; Ana Treviño; Carmen de Mendoza; Víctor Moreno-Torres; Ilduara Pintos; Pablo Barreiro; Octavio Corral
Journal:  Infez Med       Date:  2022-09-01

2.  Collagen IV (COL4A1, COL4A2), a Component of the Viral Biofilm, Is Induced by the HTLV-1 Oncoprotein Tax and Impacts Virus Transmission.

Authors:  Sebastian Millen; Christine Gross; Norbert Donhauser; Melanie C Mann; Jean-Marie Péloponèse; Andrea K Thoma-Kress
Journal:  Front Microbiol       Date:  2019-10-23       Impact factor: 5.640

Review 3.  Blocking HTLV-1/2 silent transmission in Brazil: Current public health policies and proposal for additional strategies.

Authors:  Carolina Rosadas; Maria Luiza B Menezes; Bernardo Galvão-Castro; Tatiane Assone; Angélica E Miranda; Mayra G Aragón; Adele Caterino-de-Araujo; Graham P Taylor; Ricardo Ishak
Journal:  PLoS Negl Trop Dis       Date:  2021-09-23

4.  HTLV-1 Is Also a Sexually Transmitted Infection.

Authors:  Mariana Martel; Eduardo Gotuzzo
Journal:  Front Public Health       Date:  2022-03-31

Review 5.  HTLV-1 Transmission and HIV Pre-exposure Prophylaxis: A Scoping Review.

Authors:  Daniel Bradshaw; Graham Philip Taylor
Journal:  Front Med (Lausanne)       Date:  2022-04-29

6.  HTLV-1 Extracellular Vesicles Promote Cell-to-Cell Contact.

Authors:  Daniel O Pinto; Catherine DeMarino; Michelle L Pleet; Maria Cowen; Heather Branscome; Sarah Al Sharif; Jennifer Jones; Helene Dutartre; Benjamin Lepene; Lance A Liotta; Renaud Mahieux; Fatah Kashanchi
Journal:  Front Microbiol       Date:  2019-09-18       Impact factor: 5.640

7.  Characterizing the Interaction between the HTLV-1 Transactivator Tax-1 with Transcription Elongation Factor ELL2 and Its Impact on Viral Transactivation.

Authors:  Stephan Kohrt; Sarah Strobel; Melanie C Mann; Heinrich Sticht; Bernhard Fleckenstein; Andrea K Thoma-Kress
Journal:  Int J Mol Sci       Date:  2021-12-18       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.